Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1995;15:543-549

This Article
Right arrow Full Text
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stalenhoef, A. F. H.
Right arrow Articles by Zechner, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stalenhoef, A. F. H.
Right arrow Articles by Zechner, R.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1995;15:543-549.)
© 1995 American Heart Association, Inc.


Articles

The 17th Annual Meeting of the European Lipoprotein Club

Anton F. H. Stalenhoef; Victor W. Armstrong; Armin Steinmetz; Marja-Riitta Taskinen; Rudolf Zechner

Correspondence to Dr A.F.H. Stalenhoef, Department of Medicine, Division of General Internal Medicine, University Hospital Nijmegen, PO Box 9101, 6500 HB Nijmegen, The Netherlands.


Key Words: meeting summary • European Lipoproteins Club


*    Introduction
 
The European Lipoprotein Club met September 12-15, 1994, in Tutzing, Germany. There were 92 participants from 12 European countries and the United States.

Dr John Wetterau of Bristol-Myers Squibb Pharmaceutical Research Institute opened the meeting with a State of the Art Lecture entitled "The Microsomal Triglyceride Transfer Protein: Characterization and Role in the Assembly of VLDL and Chylomicrons." The microsomal triglyceride transfer protein (MTP) is a soluble lipid transfer protein found in the lumen of microsomes of liver and intestine. This heterodimer is composed of the multifunctional protein disulfide isomerase and a unique large subunit of molecular weight 97 000. In vitro, MTP catalyzes the transport of triglyceride, cholesteryl ester, and a variety of phospholipids between membranes. When one compares the fractional transfer rates, MTP appears to selectively bind and transport hydrophobic neutral lipid. However, the assays used to characterize MTP have at least 100-fold more phospholipid than neutral lipid, so in these assays, MTP actually transports more phospholipid than neutral lipid.

Abetalipoproteinemia is an autosomal recessive disease in which the subjects have a defect in the assembly and secretion of VLDL and chylomicrons. Recent studies by Dr Wetterau of abetalipoproteinemic subjects showed that MTP activity and the unique large subunit were absent in all four unrelated subjects studied. Frame shift, nonsense, and point mutations that explain the absence of MTP were found in these four subjects. These studies indicated that an absence of MTP function causes abetalipoproteinemia and that MTP is required for the assembly of apoB–containing lipoproteins.

Hela . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
CirculationHome page
D. L. Sprecher, B. V. Harris, E. A. Stein, P. S. Bellet, L. M. Keilson, and L. A. Simbartl
Higher Triglycerides, Lower High-Density Lipoprotein Cholesterol, and Higher Systolic Blood Pressure in Lipoprotein Lipase–Deficient Heterozygotes: A Preliminary Report
Circulation, December 15, 1996; 94(12): 3239 - 3245.
[Abstract] [Full Text]